Today’s front page Washington Post article by Joby Warrick on the Ivins case appears to present the FBI’s side of the story. I will post excerpts from the article and comment (in italics) on its inconsistencies. Abshire focused her lens on a moldlike clump. Anthrax bacteria were growing here, but some of the cells were…

Robert Roos News Editor Oct 23, 2008 (CIDRAP News) – The federal Advisory Committee on Immunization Practices (ACIP) has opened the door to voluntary anthrax vaccination for first responders, revising an 8-year-old recommendation against that step. The committee, meeting yesterday, said the risk of anthrax exposure for emergency responders is low but “may not be…

CDC published a report October 1 on its very expensive, 43 month-long trial of anthrax vaccine, but inexplicably discussed only the first 7 months and only 65% of the subjects. No explanation was given for why only partial data were provided in this important paper. Bloomberg may provide the reason; the selected data discussed in…

Representative Rush Holt, Chairman of the House Select Intelligence Oversight Panel of the House Committee on Appropriations, and a Representative whose constituents were directly affected by the anthrax attacks, has requested that the National Academy of Science also answer the following questions, should it elect to undertake an independent review of the FBI’s scientific methods…

The Public Readiness and Emergency Preparedness Act, also known as Division C of P.L. 109-148 (2005) limits liability with respect to pandemic flu and other public health countermeasures. A Congressional Research Service Report for Congress by Henry Cohen, Legislative Attorney notes the following: 1. The ONLY circumstance in which a shielded person could be held…

Mayur Pahilajani – iStockAnalyst WriterNew York, NY Shares of Emergent Biosolutions Inc (NYSE: EBS) topped 52-week mark after the bell on Friday as investors gained confidence in the company after the Rockville-based biotech’s profitable anthrax treatments won emergency protection. On October 9, the firm announced that the vaccine Biothrax and its Anthrax Immune Globulin, both…

Fri, Oct. 17, 2008 By ALAN BAVLEY The Kansas City Star Sure, the economy is causing a crisis, but what about anthrax? How about smallpox? In a little noticed move, federal officials this month have declared a series of public health emergencies relating to potential weapons of biological terror. On Oct. 1, Health and Human…

Elaine GrossmanGlobal Security Newswire Oct. 17, 2008WASHINGTON – The U.S. Health and Human Services Department early this month moved to shield government, industry and business officials from lawsuits filed by those who have received the anthrax vaccine (see GSN , Sept. 5, 2007). Health and Human Services Secretary Michael Leavitt established legal immunity for public…

In a particularly Kafka-esque memorandum, Department of Homeland Security Secretary Chertoff wrote to Department of Health and Human Services Secretary Mike Leavitt on September 23, 2008 and said bluntly that he had no evidence for an anthrax emergency… however, there exists a non-negligible risk there may someday be one, so feel free to invoke the…

October 23, 2007: GAO says HHS has announced that it will issue another rPA anthrax vaccine proposal but has not formally reviewed what went wrong with the VaxGen contract. “They may repeat their mistakes in the absence of a corrective plan,” the report says.

Elaine GrossmanGlobal Security Newswire: Oct. 16, 2008 WASHINGTON – A U.S. government advisory panel next week could recommend that state and local public health officials consider administering anthrax vaccines to as many as 3 million first responders nationwide, Global Security Newswire has learned. The panel, convened by the Centers for Disease Control and Prevention, would…

Excerpts from Wired Blog: The emergency was declared earlier this month by the Department of Health and Human Services, and will last until 2015. Whether it will protect public health is debatable, but it will certainly protect makers of faulty anthrax vaccines. The act is supposed to be invoked when the Secretary of Homeland Security…

The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law in December, 2005, is a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The Act does not specify any criteria for determining the existence…

This week DHHS contracted to buy 14.5 million more doses of EBS’ anthrax vaccine. It has already purchased about 25 million doses for a civilian stockpile. This supply may be where the vaccine for first responders will come from. GAO reported in 2007 on the large losses DHHS will incur when the anthrax vaccine outdates;…

The October 3 article by Yudhijit Bhattacharjee (below) discusses the FBI’s request to NAS. How can the National Academy of Sciences answer whether the scientific work would meet evidentiary standards in a court of law? They are scientists, not lawyers. The Federal Bureau of Investigation (FBI) has provided the U.S. National Academy of Sciences (NAS)…

1. Omitting one dose, and injecting the vaccine deeper into muscle was widely reported to reduce adverse effects. But only brief local reactions at the skin are reduced, as one might expect with a deeper shot. The occurrence of the more consequential systemic adverse events was “not significantly influence[d]” by route of administration. 2. Women…

Thanks to Marisa Taylor at McClatchy Newspapers for this well-researched report on where the release of the records stands, and how the FBI justifies withholding these records.